Hamutal Engel

630 total citations
21 papers, 470 citations indexed

About

Hamutal Engel is a scholar working on Molecular Biology, Physiology and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Hamutal Engel has authored 21 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Hamutal Engel's work include Protein Structure and Dynamics (5 papers), Alzheimer's disease research and treatments (5 papers) and Spectroscopy and Quantum Chemical Studies (4 papers). Hamutal Engel is often cited by papers focused on Protein Structure and Dynamics (5 papers), Alzheimer's disease research and treatments (5 papers) and Spectroscopy and Quantum Chemical Studies (4 papers). Hamutal Engel collaborates with scholars based in Israel, Italy and United States. Hamutal Engel's co-authors include Dan Thomas Major, Ehud Gazit, Dvir Doron, Avi Raveh, Micha Fridman, Daniel Segal, Edward Pichinuk, Amnon Kohen, Yael Roichman and Judith Berman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Hamutal Engel

21 papers receiving 467 citations

Peers

Hamutal Engel

PHYSI

PHARM

Zhiguang Jia United States

Noriyoshi Isozumi Japan

Mehmet Özbil Türkiye

Yuri V. Mezentsev Russia

Ziao Fu United States

Gergely Tóth United Kingdom

Ningning Wei China

Mehriar Amininasab Iran

Antonia Stank Germany

Beihong Ji United States

Zhiguang Jia United States

Hamutal Engel

502 ×2.2

85 ×0.9

PHYSI

54 ×0.9

79 ×1.5

PHARM

44 ×0.9

Citations per year, relative to Hamutal Engel Hamutal Engel (= 1×) peers Zhiguang Jia

Countries citing papers authored by Hamutal Engel

Since Specialization

Citations

This map shows the geographic impact of Hamutal Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamutal Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamutal Engel more than expected).

Fields of papers citing papers by Hamutal Engel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamutal Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamutal Engel. The network helps show where Hamutal Engel may publish in the future.

Co-authorship network of co-authors of Hamutal Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Hamutal Engel. A scholar is included among the top collaborators of Hamutal Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamutal Engel. Hamutal Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaham‐Niv, Shira, Assaf Ezra, Dor Zaguri, et al.. (2024). Targeting phenylalanine assemblies as a prospective disease-modifying therapy for phenylketonuria. Biophysical Chemistry. 308. 107215–107215. 3 indexed citations

Peretz, Asher, Adva Yeheskel, Hamutal Engel, et al.. (2022). Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K ⁺ channels for atrial fibrillation treatment. Proceedings of the National Academy of Sciences. 119(34). e2202926119–e2202926119. 15 indexed citations

Paul, Ashim, Elad Arad, Hamutal Engel, et al.. (2021). Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone–Dopamine hybrid. FEBS Journal. 288(14). 4267–4290. 19 indexed citations

Meli, Massimiliano, et al.. (2021). Chemical Chaperones Modulate the Formation of Metabolite Assemblies. International Journal of Molecular Sciences. 22(17). 9172–9172. 10 indexed citations

Engel, Hamutal, et al.. (2020). TOR Complex 2- independent mutations in the regulatory PIF pocket of Gad8AKT1/SGK1 define separate branches of the stress response mechanisms in fission yeast. PLoS Genetics. 16(11). e1009196–e1009196. 4 indexed citations

Mimouni, Michael, et al.. (2020). Inhibition of amyloid fibrillation of γD-crystallin model peptide by the cochineal Carmine. International Journal of Biological Macromolecules. 169. 342–351. 4 indexed citations

Ganz, Javier, Marina Shenkman, Shibendu Shekhar Roy, et al.. (2020). A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease models. Scientific Reports. 10(1). 6875–6875. 45 indexed citations

Yeheskel, Adva, et al.. (2020). Structural basis of heterotetrameric assembly and disease mutations in the human cis-prenyltransferase complex. Nature Communications. 11(1). 5273–5273. 19 indexed citations

Engel, Hamutal, et al.. (2020). Chemical Modifications Reduce Auditory Cell Damage Induced by Aminoglycoside Antibiotics. Journal of the American Chemical Society. 142(6). 3077–3087. 23 indexed citations

10.

Meli, Massimiliano, Hamutal Engel, Dana Laor Bar‐Yosef, Ehud Gazit, & Giorgio Colombo. (2019). Mechanisms of Metabolite Amyloid Formation: Computational Studies for Drug Design against Metabolic Disorders. ACS Medicinal Chemistry Letters. 10(4). 666–670. 9 indexed citations

11.

Bar‐Yosef, Dana Laor, Shira Shaham‐Niv, Dor Zaguri, et al.. (2019). Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation. Nature Communications. 10(1). 62–62. 43 indexed citations

12.

Arad, Elad, Chen Shemesh, Edward Pichinuk, et al.. (2019). Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model. Cellular and Molecular Life Sciences. 77(14). 2795–2813. 56 indexed citations

13.

Velayudhannair, Krishnakumar, Edward Pichinuk, Hamutal Engel, et al.. (2018). Integrating in vitro and in silico approaches to evaluate the “dual functionality” of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(7). 1565–1575. 39 indexed citations

14.

Benhamou, Raphael I., Maayan Bibi, Hamutal Engel, et al.. (2017). Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida Cells. ACS Chemical Biology. 12(7). 1769–1777. 60 indexed citations

15.

Engel, Hamutal, et al.. (2015). Nuclear quantum effects in chemical reactions via higher-order path-integral calculations. Chemical Physics. 450-451. 95–101. 4 indexed citations

16.

Dixit, Mudit, Hamutal Engel, Doron Aurbach, et al.. (2015). Classical and Quantum Modeling of Li and Na Diffusion in FePO₄. The Journal of Physical Chemistry C. 119(28). 15801–15809. 32 indexed citations

17.

Doron, Dvir, et al.. (2014). Multiscale Quantum‐Classical Simulations of Enzymes. Israel Journal of Chemistry. 54(8-9). 1108–1117. 5 indexed citations

18.

Major, Dan Thomas, et al.. (2012). Hybrid Quantum and Classical Simulations of the Formate Dehydrogenase Catalyzed Hydride Transfer Reaction on an Accurate Semiempirical Potential Energy Surface. Journal of Chemical Theory and Computation. 8(11). 4786–4796. 25 indexed citations

19.

Engel, Hamutal, et al.. (2011). Path-Integral Calculations of Nuclear Quantum Effects in Model Systems, Small Molecules, and Enzymes via Gradient-Based Forward Corrector Algorithms. Journal of Chemical Theory and Computation. 7(5). 1273–1286. 27 indexed citations

20.

Engel, Hamutal & Kenneth G. Kay. (2008). Global uniform semiclassical approximation for Clebsch-Gordan coefficients. The Journal of Chemical Physics. 128(9). 94104–94104. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact